Scinovex
reviewTop 1% cited

P<scp>ROTOFIBRILS</scp>, P<scp>ORES</scp>, F<scp>IBRILS, AND</scp> N<scp>EURODEGENERATION</scp>: Separating the Responsible Protein Aggregates from The Innocent Bystanders

Annual Review of Neuroscience · 2003 · Vol. 26(1) · pp. 267–298
Byron CaugheyPeter T. Lansbury

Abstract

Many neurodegenerative diseases, including Alzheimer's and Parkinson's and the transmissible spongiform encephalopathies (prion diseases), are characterized at autopsy by neuronal loss and protein aggregates that are typically fibrillar. A convergence of evidence strongly suggests that protein aggregation is neurotoxic and not a product of cell death. However, the identity of the neurotoxic aggregate and the mechanism by which it disables and eventually kills a neuron are unknown. Both biophysical studies aimed at elucidating the precise mechanism of in vitro aggregation and animal modeling studies support the emerging notion that an ordered prefibrillar oligomer, or protofibril, may be responsible for cell death and that the fibrillar form that is typically observed at autopsy may actually be neuroprotective. A subpopulation of protofibrils may function as pathogenic amyloid pores. An analogous mechanism may explain the neurotoxicity of the prion protein; recent data demonstrates that the disease-associated, infectious form of the prion protein differs from the neurotoxic species. This review focuses on recent experimental studies aimed at identification and characterization of the neurotoxic protein aggregates.

Prion Diseases and Protein MisfoldingAlzheimer's disease research and treatmentsNeurological diseases and metabolismNeurotoxicityProtein aggregationProgrammed cell deathNeuroprotectionNeurodegenerationChemistryAmyloid (mycology)NeuroscienceCell biologyBiology

MeSH terms

Superoxide Dismutase-1Amyotrophic Lateral SclerosisAnimalsDisease Models, AnimalHumansNerve DegenerationNerve Tissue ProteinsPrionsSuperoxide DismutaseAmyloid beta-PeptidesNeurofibrillary TanglesPrPSc ProteinsNeurodegenerative DiseasesSynucleinsPlaque, Amyloid
Citations
1,643
FWCI
34.28
field-weighted impact
References
200
Percentile
100%
vs. same field & year
Citations per year
Cited by
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
Journal of Medicinal Chemistry · 2008 · 1,103 citations
Alzheimer’s Disease: The Challenge of the Second Century
Science Translational Medicine · 2011 · 1,414 citations
TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration
Human Molecular Genetics · 2010 · 1,001 citations
Structural conversion of neurotoxic amyloid-β1–42 oligomers to fibrils
Nature Structural & Molecular Biology · 2010 · 1,085 citations
The amyloid state and its association with protein misfolding diseases
Nature Reviews Molecular Cell Biology · 2014 · 2,362 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

P<scp>ROTOFIBRILS</scp>, P<scp>ORES</scp>, F<scp>IBRILS, AND</scp> N<scp>EURODEGENERATION</scp>: Separating the Responsible Protein Aggregates from The Innocent Bystanders · Scinovex